Medicine and Dentistry
Krukenberg Tumor
100%
Malignant Neoplasm
68%
Cervical Cancer
55%
Ovarian Cancer
50%
Neoadjuvant Chemotherapy
50%
Snail
50%
Histopathology
50%
Ascites
50%
Clear Cell Carcinoma
50%
Cervicectomy
50%
DNA Repair
50%
Livin
50%
Epileptic Absence
50%
Phosphotransferase
50%
Transactivation
50%
Endometrial Stromal Sarcoma
50%
Familial Cancer
50%
Pigment Epithelium Derived Factor
50%
Debulking Surgery
50%
Muellerian Inhibiting Factor
50%
Mesenchymal-Epithelial Transition
50%
Uvomorulin
50%
Cytoreductive Surgery
50%
Papillomavirus Infection
50%
Papillary Carcinoma
50%
Cervix
44%
Recurrent Disease
36%
Paclitaxel
35%
Carboplatin
35%
Overall Survival
33%
Epidermal Growth Factor Receptor
30%
Signal Transduction
30%
Adenocarcinoma
30%
Prognostic Factor
30%
Hazard Ratio
30%
Disease
28%
Cancer Cell
28%
Programmed Cell Death
25%
Abdominal Distension
25%
Gene Function
25%
Magnetic Resonance Imaging
25%
Cellular Stress Response
25%
Pancreas Cancer
25%
Cancer Risk
25%
Cell DNA
25%
Peritoneal Biopsy
25%
Breast Cancer
25%
DNA Damage
25%
Digestive System Surgery
25%
DNA Damage Response
25%
Keyphrases
Interval Debulking Surgery
50%
Vav1
50%
Pre-metastatic Niche
50%
Clinical Outcomes
50%
Hereditary Tumors
50%
Synthetic Lethal
50%
DNA Repair Inhibitors
50%
Early-stage Cervical Cancer
50%
Advanced Ovarian Cancer
50%
Surgical Outcomes
50%
Neoadjuvant Chemotherapy
50%
Fertility Sparing
50%
Abdominal Radical Trachelectomy
50%
Immune Cytotoxicity
50%
Livin
50%
Debulking Surgery
50%
Choriocarcinomatous Differentiation
50%
Endometrial Stromal Sarcoma
50%
Pigment Epithelium-derived Factor
50%
Cervical Clear Cell Carcinoma
50%
Ovarian Cancer Patients
50%
Clear Cell Carcinoma of the Cervix
50%
Serum anti-Müllerian Hormone
50%
Anti-mullerian Hormone Levels
50%
Immunophenotypic Profile
50%
Hazard Ratio
37%
Decisional Conflict Scale
33%
Overall Survival
27%
Metastatic Colonization
25%
Mixed Carcinoma
25%
Advanced Stage
25%
Omental Cake
25%
Cancer Cells
25%
Periostin Expression
16%
Ovarian Function
16%
Video Viewing
16%
Decisional Conflict
16%
Operable Breast Cancer
16%
FIGO Stage I
14%
Carboplatin
12%
Chemotherapy
12%
Residual Cancer
12%
Peritoneal Cancer
12%
Cell Displacement
12%
Stage IV Disease
12%
Neoadjuvant
12%
Cox Proportional Hazards Model
12%
Residual Disease
12%
Histological Grade
12%
Tumor Inflammation
12%
Biochemistry, Genetics and Molecular Biology
Bleomycin
50%
Periostin
50%
Oligonucleotide
50%
Epidermal Growth Factor Receptor
50%
Antisense
50%
Wart Virus
50%
Mesenchymal-Epithelial Transition
50%
Transactivation
50%
Cadherin
50%
Mammalian Target of Rapamycin
40%
Upregulation
22%
Actin
22%
Overall Survival
20%
Phosphatase
20%
Tensin
20%
Transcriptional Repressor
16%
Morphology
16%
Stress Fiber
16%
Western Blot
16%
Surface Property
16%
RNA Interference
16%
Downregulation
16%
Cancer Cell
16%
Messenger RNA
16%
Quantitative Reverse Transcription Polymerase Chain Reaction
16%
Cell Adhesion
16%
Guanine Nucleotide Exchange Factor
16%
Human Papillomavirus Type 18
10%
Gene Amplification
10%
Tyrosine
10%
P53
10%
Survival Rate
10%
Fluorescence in Situ Hybridization
10%
Cancer Staging
10%
Signal Transduction
10%
Mechanistic Target of Rapamycin
10%
Immunostaining
10%
Human Papillomavirus Type 16
10%
Nested Polymerase Chain Reaction
10%
Human Papillomavirus Type 58
10%
Polymerase Chain Reaction
10%
Mouse
6%
Carcinogenesis
6%
Myofibroblast
6%
Messenger RNA
6%
Cancer Mortality
6%
